Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Puerperal Disorders

ng-nitroarginine methyl ester has been researched along with Puerperal Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gangula, PR; Wimalawansa, SJ; Yallampalli, C1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Puerperal Disorders

ArticleYear
Progesterone up-regulates vasodilator effects of calcitonin gene-related peptide in N(G)-nitro-L-arginine methyl ester-induced hypertension.
    American journal of obstetrics and gynecology, 1997, Volume: 176, Issue:4

    Topics: Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Drug Interactions; Female; Hypertension; NG-Nitroarginine Methyl Ester; Pregnancy; Pregnancy Complications, Cardiovascular; Progesterone; Puerperal Disorders; Rats; Rats, Sprague-Dawley; Up-Regulation; Vasodilation

1997